Marijuana ETF

Cannabis Science ( CBIS - OTC ) recently hit $0.065 on high volume topping 41 million shares, and is presently consolidating . We expect this company to again attempt a breakout above its yearly high. This company has the goods , a highly experienced management team and a rapidly expanding market place. Serious investors should ride the next wave and place these shares on their BUY LIST

Cannabis Science Canada recently initiated operations , acquiring land and licenses from operators already doing business in Canada. We anticipate an aggressive expansion into Canada propelling the shares still higher.

Cannabis Science’s primary objective is to research and develop U.S. Food and Drug Administration (FDA)-approved, cannabinoid-based medicine to fight a number of targeted critical ailments, including various Cancers, Neurological Conditions, PTSD, Sleep Deprivation, Chronic Pain, HIV/AIDS, Autism, Parkinson’s Disease, Epilepsy, Chronic Obstructive Pulmonary Disease (COPD), and others. Cannabis Science and its collaborators are well underway on a number of research projects targeting Lung Cancer, Pancreatic Cancer, Chronic Pelvic Pain, and Oro-bucco-lingual Dyskinesias. MORE NEWS ON CBIS

ELLIOT WAVE SAYS BUY BUY BUY MARIJUANA STOCKS

Horizons Medical Marijuana Life Sciences ETF (HMMJ) or (OTC:HMLSF) is a Canadian ETF that tracks many of the common stocks in the sector. It only started in 2017, but from the 2018 peak there is a very clear Elliott Wave corrective "WXY" flat pattern. Top Cannabis Stocks

Off the December low is a clear impulsive 5-wave move up that has proportions in-line with being only the wave 1 of a much larger move starting. It is currently retracing correctively as an abc for wave 2 with support in this 20-17 region. The 3rd wave should head toward the 40s into 2020 provided support holds. Wall Street Daily

ELLIOT WAVE THEORY - VIEW VIDEO - LIVE CHART AND COMMENT

In the video above we discuss some of our picks within that sector with string setups for upside soon: Canopy Growth (CGC) should have at least one nice swing higher remaining for the c-wave of a fifth near the end of a larger Ending Diagonal structure.

With support extending from here to lower 30s but a normal target of 82+ for the (NYSE:C)-wave the Risk:Reward here on CGC is favorable 1:4. Cronos Group (CRON) while also in a larger Diagonal stucture is due for all of the fifth wave targeting 32+ (easily as high as 38-45+) from the 14-12 support region. CNBC - Next Supercomputer - Fastest Machine Alive

Canntrust Holdings (CTST) has very thin data for parts of the larger Primary degree wave 1 but the consolidation off the 2018 high is very clean as an expanded flat implying that the underlying trend is very strongly bullish (b/c it stretched the (NYSE:B)-wave to a new high). Off the December low we have similar strong wave (1) and a nice clear ABC consolidation as (2) w/ support here in the 6s for a (3) of P.3 targeting 23-28. Hexo Corp (HEXO) mirrors CTST closely with the same expanded flat and 1-2 start of the third with the (3) of P.3 targeting 14.44 or 20.86.

Tilray Inc (TLRY) was a newer IPO that came on the scene with a LOT of hype but has since faded perfectly according to the Elliott Wave path we laid out for it. Warren Buffett $10 Bill 8% Loan To OXY - Raymond James

We pretty much called a top on it in September recognizing that the final extension of the initial five waves up from IPO was a non-sustainable blow-off top and based on our CABpIPO pattern were looking MUCH lower. In October as it was nearing the end of a B wave bounce we were able to narrow our projection for a C-wave down targeting the 40s, as that pattern as followed through we have continued to add more detail for specific bottoming targets. Even if just a larger corrective bounce again TLRY offers substantial upside potential, and the near 43% short interest could provide some serious fuel for a short squeeze.

Disney Soars 40% - Strong Buy